Variant report
Variant | esv2759680 |
---|---|
Chromosome Location | chr9:21499624-21526526 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:351)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 2)
- miRNA target sites (count:0)
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | BCL3 | chr9:21501331-21508410 | A549 | lung: | n/a | chr9:21506204-21506213 |
2 | BCL3 | chr9:21519608-21520690 | A549 | lung: | n/a | chr9:21519928-21519937 |
3 | BCL3 | chr9:21499752-21501285 | A549 | lung: | n/a | n/a |
4 | BCL3 | chr9:21499921-21500395 | A549 | lung: | n/a | n/a |
5 | BCL3 | chr9:21506616-21507704 | A549 | lung: | n/a | n/a |
6 | BCL3 | chr9:21501977-21502583 | A549 | lung: | n/a | n/a |
7 | BCL3 | chr9:21508689-21509632 | A549 | lung: | n/a | n/a |
8 | BCL3 | chr9:21503475-21506429 | A549 | lung: | n/a | chr9:21506204-21506213 |
9 | BCL3 | chr9:21500520-21501100 | A549 | lung: | n/a | n/a |
10 | CBX3 | chr9:21519763-21526025 | HCT-116 | colon: | n/a | n/a |
11 | CBX3 | chr9:21520811-21522028 | HCT-116 | colon: | n/a | n/a |
12 | CBX3 | chr9:21526174-21527163 | HCT-116 | colon: | n/a | n/a |
13 | CBX3 | chr9:21522147-21524471 | HCT-116 | colon: | n/a | n/a |
14 | CEBPB | chr9:21519556-21521968 | HCT-116 | colon: | n/a | n/a |
15 | CEBPB | chr9:21506801-21507249 | Hela-S3 | cervix: | n/a | n/a |
16 | CEBPB | chr9:21513524-21513835 | IMR90 | lung: | n/a | n/a |
17 | CEBPB | chr9:21501197-21501480 | A549 | lung: | n/a | n/a |
18 | CEBPB | chr9:21519283-21525730 | HCT-116 | colon: | n/a | n/a |
19 | CEBPB | chr9:21506792-21507249 | IMR90 | lung: | n/a | n/a |
20 | CEBPB | chr9:21506492-21507694 | HCT-116 | colon: | n/a | chr9:21507245-21507257 |
21 | CTCF | chr9:21502460-21502610 | NHDF-neo | bronchial: | n/a | n/a |
22 | CTCF | chr9:21500904-21500959 | GM20000 | blood: | n/a | n/a |
23 | CTCF | chr9:21509715-21509808 | GM10248 | blood: | n/a | n/a |
24 | CTCF | chr9:21512071-21512100 | Fibrobl | skin: | n/a | n/a |
25 | EGR1 | chr9:21523516-21524894 | HCT-116 | colon: | n/a | n/a |
26 | ELF1 | chr9:21506772-21507158 | A549 | lung: | n/a | chr9:21507058-21507069 |
27 | ELF1 | chr9:21508706-21509493 | HCT-116 | colon: | n/a | n/a |
28 | ELF1 | chr9:21519892-21526918 | HCT-116 | colon: | n/a | n/a |
29 | EP300 | chr9:21506819-21507193 | Hela-S3 | cervix: | n/a | n/a |
30 | FOS | chr9:21508367-21508583 | MCF10A-Er-Src | breast: | n/a | chr9:21508424-21508431 chr9:21508421-21508432 chr9:21508423-21508431 chr9:21508423-21508432 |
31 | FOS | chr9:21513418-21513843 | MCF10A-Er-Src | breast: | n/a | n/a |
32 | FOS | chr9:21505465-21505789 | MCF10A-Er-Src | breast: | n/a | n/a |
33 | FOS | chr9:21513445-21513869 | MCF10A-Er-Src | breast: | n/a | n/a |
34 | FOS | chr9:21505386-21505787 | MCF10A-Er-Src | breast: | n/a | n/a |
35 | FOS | chr9:21506828-21507267 | MCF10A-Er-Src | breast: | n/a | n/a |
36 | FOS | chr9:21506889-21507250 | MCF10A-Er-Src | breast: | n/a | n/a |
37 | FOS | chr9:21506846-21507207 | MCF10A-Er-Src | breast: | n/a | n/a |
38 | FOS | chr9:21519654-21519864 | MCF10A-Er-Src | breast: | n/a | n/a |
39 | FOS | chr9:21506911-21507422 | HUVEC | blood vessel: | n/a | n/a |
40 | FOS | chr9:21505429-21505786 | MCF10A-Er-Src | breast: | n/a | n/a |
41 | FOS | chr9:21519640-21519884 | MCF10A-Er-Src | breast: | n/a | n/a |
42 | FOS | chr9:21506738-21507319 | MCF10A-Er-Src | breast: | n/a | n/a |
43 | FOS | chr9:21519635-21519835 | MCF10A-Er-Src | breast: | n/a | n/a |
44 | FOS | chr9:21513438-21513821 | MCF10A-Er-Src | breast: | n/a | n/a |
45 | FOS | chr9:21508277-21508670 | HUVEC | blood vessel: | n/a | chr9:21508424-21508431 chr9:21508421-21508432 chr9:21508423-21508431 chr9:21508423-21508432 |
46 | FOS | chr9:21505493-21505766 | MCF10A-Er-Src | breast: | n/a | n/a |
47 | FOS | chr9:21513417-21513900 | MCF10A-Er-Src | breast: | n/a | n/a |
48 | FOSL1 | chr9:21506525-21507527 | HCT-116 | colon: | n/a | chr9:21506578-21506590 |
49 | FOSL1 | chr9:21519573-21524793 | HCT-116 | colon: | n/a | n/a |
50 | FOSL1 | chr9:21505232-21505921 | HCT-116 | colon: | n/a | n/a |
No data |
(count:2 , 50 per page) page:
1
No data |
miRNA name | Chromosome Location | mirBase accession |
---|---|---|
hsa-miR-31-3p | chr9:21512120-21512141 | MIMAT0004504 |
hsa-miR-31-5p | chr9:21512157-21512177 | MIMAT0000089 |
No data |
Variant related genes | Relation type |
---|---|
MIR31 | TF binding region |
ENSG00000264379 | TF binding region |
ENSG00000134824 | chromatin interactions |
ENSG00000149485 | chromatin interactions |
JAZF1 | Mature miRNA region |
MPRIP | Mature miRNA region |
CYP27B1 | Mature miRNA region |
HEATR2 | Mature miRNA region |
CIPC | Mature miRNA region |
SFXN1 | Mature miRNA region |
TNKS2 | Mature miRNA region |
DACT3 | Mature miRNA region |
PPP2R5C | Mature miRNA region |
XK | Mature miRNA region |
ITGA5 | Mature miRNA region |
INHBA | Mature miRNA region |
MYO1D | Mature miRNA region |
PTPRJ | Mature miRNA region |
RET | Mature miRNA region |
C2CD5 | Mature miRNA region |
HIST1H2BI | Mature miRNA region |
RANGAP1 | Mature miRNA region |
RASA1 | Mature miRNA region |
RICTOR | Mature miRNA region |
DKK1 | Mature miRNA region |
HOXA7 | Mature miRNA region |
UBA6 | Mature miRNA region |
SATB2 | Mature miRNA region |
ARL6IP5 | Mature miRNA region |
ETS1 | Mature miRNA region |
CREG1 | Mature miRNA region |
HOXC13 | Mature miRNA region |
MED12 | Mature miRNA region |
DNAJC5 | Mature miRNA region |
DDX19A | Mature miRNA region |
CDK1 | Mature miRNA region |
NFATC2IP | Mature miRNA region |
EDC3 | Mature miRNA region |
PRKCE | Mature miRNA region |
ZNF275 | Mature miRNA region |
SRRM2 | Mature miRNA region |
PPIL2 | Mature miRNA region |
STOML2 | Mature miRNA region |
SELE | Mature miRNA region |
RHOA | Mature miRNA region |
AKAP8L | Mature miRNA region |
PPP2R2A | Mature miRNA region |
CASR | Mature miRNA region |
MET | Mature miRNA region |
RPL37A | Mature miRNA region |
EXOSC5 | Mature miRNA region |
ACADVL | Mature miRNA region |
NFAT5 | Mature miRNA region |
MMP16 | Mature miRNA region |
KLF13 | Mature miRNA region |
MLH1 | Mature miRNA region |
NOL9 | Mature miRNA region |
HIST1H2BJ | Mature miRNA region |
FZD3 | Mature miRNA region |
ZC3H12C | Mature miRNA region |
ARPC5 | Mature miRNA region |
PPIA | Mature miRNA region |
RPS4Y1 | Mature miRNA region |
NDFIP2 | Mature miRNA region |
SLC9A6 | Mature miRNA region |
RPA1 | Mature miRNA region |
ILF2 | Mature miRNA region |
DMD | Mature miRNA region |
FOXP3 | Mature miRNA region |
TXNDC5 | Mature miRNA region |
TRIB3 | Mature miRNA region |
NUS1 | Mature miRNA region |
RPS7 | Mature miRNA region |
ATP2A2 | Mature miRNA region |
PCSK1N | Mature miRNA region |
GLI2 | Mature miRNA region |
FLNA | Mature miRNA region |
YY1 | Mature miRNA region |
DBR1 | Mature miRNA region |
TRRAP | Mature miRNA region |
STK40 | Mature miRNA region |
GYG1 | Mature miRNA region |
FAM134C | Mature miRNA region |
HIF1AN | Mature miRNA region |
MCM2 | Mature miRNA region |
LATS2 | Mature miRNA region |
NUP188 | Mature miRNA region |
ZC3H18 | Mature miRNA region |
LRRC59 | Mature miRNA region |
C1orf198 | Mature miRNA region |
SMEK2 | Mature miRNA region |
HIST1H2BK | Mature miRNA region |
MCM4 | Mature miRNA region |
NUMB | Mature miRNA region |
TNRC6B | Mature miRNA region |
PEX19 | Mature miRNA region |
CXCL12 | Mature miRNA region |
GHITM | Mature miRNA region |
ICAM1 | Mature miRNA region |
EXOC6 | Mature miRNA region |
RDX | Mature miRNA region |
NOP56 | Mature miRNA region |
TIAM1 | Mature miRNA region |
AGO1 | Mature miRNA region |
RAN | Mature miRNA region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs7849420 | chr9:21499624-21499625 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | disease |
2 | rs536393758 | chr9:21499653-21499654 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs548758819 | chr9:21499689-21499690 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs185302550 | chr9:21499751-21499752 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs7849575 | chr9:21499793-21499794 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs9696745 | chr9:21499817-21499818 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs577893076 | chr9:21499818-21499819 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs112274556 | chr9:21499825-21499826 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs564738565 | chr9:21499838-21499839 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs78266431 | chr9:21499852-21499853 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs190063040 | chr9:21499892-21499893 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs372519854 | chr9:21499912-21499913 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs547469365 | chr9:21499928-21499929 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs573669853 | chr9:21499936-21499937 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs149996492 | chr9:21499960-21499961 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs563027792 | chr9:21499980-21499981 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs576733554 | chr9:21499992-21499993 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs369603500 | chr9:21499998-21499999 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs183220995 | chr9:21500024-21500025 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs376846537 | chr9:21500052-21500053 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs187784141 | chr9:21500088-21500089 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs192461544 | chr9:21500101-21500102 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs537321692 | chr9:21500109-21500110 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs565726775 | chr9:21500113-21500114 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs561167447 | chr9:21500115-21500116 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs58021384 | chr9:21500200-21500201 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs549884261 | chr9:21500204-21500205 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs149174200 | chr9:21500216-21500217 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs183914773 | chr9:21500248-21500249 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs551189238 | chr9:21500255-21500256 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs536246234 | chr9:21500258-21500259 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs571513040 | chr9:21500277-21500278 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs187992830 | chr9:21500287-21500288 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs191979583 | chr9:21500293-21500294 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs143330593 | chr9:21500300-21500301 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs184579261 | chr9:21500322-21500323 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs556312382 | chr9:21500339-21500340 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs148343958 | chr9:21500363-21500364 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs561150969 | chr9:21500371-21500372 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs141766298 | chr9:21500403-21500404 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs189239327 | chr9:21500416-21500417 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs12004228 | chr9:21500433-21500434 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
43 | rs111813561 | chr9:21500443-21500444 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs541370864 | chr9:21500453-21500454 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs576267512 | chr9:21500479-21500480 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs191696203 | chr9:21500523-21500524 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs530050478 | chr9:21500531-21500532 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs147103457 | chr9:21500588-21500589 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs113559909 | chr9:21500607-21500608 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs563419734 | chr9:21500625-21500626 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Breast cancer | 16608533 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 16272173 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 17133270 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Cervical cancer | 21063398 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Melanoma | 18172304 | CNVD |
Biliary cancer | 19435499 | CNVD |
Gastric cancer | 21586687 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myopathy | 18421352 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Acute lymphoblastic leukemia | 18957548 | CNVD |
Myeloproliferative neoplasm | 17564968 | CNVD |
Malignant meningioma | 17937814 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chordoma | 18071362 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Developmental delay | 19490664 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
microdeletion syndrome | 16199537 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Cancer | 20164919 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Lung cancer | 18438408 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Oral cancer | 21386901 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Breast cancer | 21785460 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21858162 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Autism | 22495311 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Developmental delay | 21147756 | CNVD |
Pilocytic astrocytoma | 18670637 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Melanoma | 22183965 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
Myoepithelioma | 18604193 | CNVD |
Cancer | 22183965 | CNVD |
Glioblastoma multiforme | 21569311 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Ewing''s sarcoma | 22429812 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Glioblastoma multiforme | 19435819 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Cutaneous T-cell lymphoma | 21881587 | CNVD |
Glioblastoma multiforme | 22291905 | CNVD |
Lung cancer | 21911935 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
head and neck squamous cell carcinoma | 21798897 | CNVD |
Cancer | 21253487 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Intracranial ependymoma | 16609018 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
T-cell acute lymphoblastic leukemia | 19406988 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
Glioma | 17123091 | CNVD |
Mental retardation | 17124404 | CNVD |
Acute lymphoblastic leukemia | 19100363 | CNVD |
Acute lymphoblastic leukemia | 18768390 | CNVD |
Leukemia | 19602459 | CNVD |
Acute monocytic leukemia | 16498392 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Leukemia | 18688285 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Acute myeloid leukemia | 19651601 | CNVD |
Coronary Disease | 20032323 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Cancer | 21732550 | CNVD |
Gastric cancer | 22539939 | CNVD |
Cancer | 21183584 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Metastatic melanoma | 18483359 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Cervical cancer | 21062161 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Glioblastoma | 17090523 | CNVD |
Lung cancer | 16773561 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Bladder cancer | 19088036 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Melanoma | 16977458 | CNVD |
Glioblastoma multiforme | 17369134 | CNVD |
Chagasic megaesophagus | 20163722 | CNVD |
Melanoma | 19566914 | CNVD |
Squamous cell cancer | 19047905 | CNVD |
Lung adenocarcinoma | 19525976 | CNVD |
Lung cancer | 19525976 | CNVD |
Hodgkin''s lymphoma | 18179710 | CNVD |
Glioma | 20126413 | CNVD |
Melanoma | 17363583 | CNVD |
Glioblastoma multiforme | 19115005 | CNVD |
Glioblastoma multiforme | 21525872 | CNVD |
Glioblastoma multiforme | 21138945 | CNVD |
Adenoid cystic carcinoma | 18332873 | CNVD |
Breast cancer | 21364760 | CNVD |
Cancer | 20581869 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Oral cancer | 22144094 | CNVD |
Lung cancer | 21569311 | CNVD |
Epilepsy | 20502679 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Breast cancer | 22522925 | CNVD |
Autism | 20858261 | CNVD |
Epilepsy | 20858261 | CNVD |
Mental retardation | 20858261 | CNVD |
Cancer | 20164920 | CNVD |
Non-small cell lung cancer | 16651412 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:21463000-21502200 | Weak transcription | HSMM | muscle |
2 | chr9:21466000-21527600 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
3 | chr9:21471600-21505600 | Weak transcription | HUVEC | blood vessel |
4 | chr9:21477000-21505800 | Weak transcription | Foreskin Fibroblast Primary Cells skin02 | Skin |
5 | chr9:21479600-21505000 | Weak transcription | NHLF | lung |
6 | chr9:21481800-21500000 | Weak transcription | Foreskin Fibroblast Primary Cells skin01 | Skin |
7 | chr9:21481800-21504800 | Weak transcription | NHDF-Ad | bronchial |
8 | chr9:21481800-21505000 | Weak transcription | Foreskin Keratinocyte Primary Cells skin02 | Skin |
9 | chr9:21482000-21504800 | Weak transcription | NHEK | skin |
10 | chr9:21483200-21501200 | Weak transcription | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
11 | chr9:21483200-21502200 | Weak transcription | Muscle Satellite Cultured Cells | -- |
12 | chr9:21483200-21504800 | Weak transcription | HMEC | breast |
13 | chr9:21487200-21500600 | Weak transcription | Osteobl | bone |
14 | chr9:21494200-21503600 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
15 | chr9:21494800-21527600 | Weak transcription | Gastric | stomach |
16 | chr9:21497400-21500000 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
17 | chr9:21498200-21500000 | Weak transcription | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
18 | chr9:21498800-21500800 | Weak transcription | Breast Myoepithelial Primary Cells | Breast |
19 | chr9:21499000-21500800 | Enhancers | A549 | lung |
20 | chr9:21499200-21503600 | Weak transcription | IMR90 fetal lung fibroblasts Cell Line | lung |
21 | chr9:21499400-21499800 | Enhancers | Fetal Intestine Small | intestine |
22 | chr9:21499400-21500200 | Weak transcription | Stomach Mucosa | stomach |
23 | chr9:21499800-21500000 | Weak transcription | Fetal Intestine Small | intestine |
24 | chr9:21500000-21500200 | Enhancers | Foreskin Fibroblast Primary Cells skin01 | Skin |
25 | chr9:21500000-21500800 | Enhancers | Fetal Intestine Small | intestine |
26 | chr9:21500000-21501000 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
27 | chr9:21500000-21503000 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
28 | chr9:21500200-21500600 | Weak transcription | Foreskin Fibroblast Primary Cells skin01 | Skin |
29 | chr9:21500200-21500800 | Enhancers | NH-A | brain |
30 | chr9:21500200-21501000 | Enhancers | Stomach Mucosa | stomach |
31 | chr9:21500400-21501000 | Enhancers | Duodenum Mucosa | Duodenum |
32 | chr9:21500600-21500800 | Enhancers | Foreskin Fibroblast Primary Cells skin01 | Skin |
33 | chr9:21500600-21502200 | Enhancers | Osteobl | bone |
34 | chr9:21500800-21501200 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
35 | chr9:21500800-21501400 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
36 | chr9:21500800-21501400 | Genic enhancers | A549 | lung |
37 | chr9:21500800-21504800 | Weak transcription | NH-A | brain |
38 | chr9:21500800-21505000 | Weak transcription | Fetal Intestine Small | intestine |
39 | chr9:21500800-21505200 | Weak transcription | Foreskin Fibroblast Primary Cells skin01 | Skin |
40 | chr9:21501000-21503800 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
41 | chr9:21501000-21505400 | Weak transcription | Stomach Mucosa | stomach |
42 | chr9:21501000-21505800 | Weak transcription | Duodenum Mucosa | Duodenum |
43 | chr9:21501200-21503200 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
44 | chr9:21501400-21502200 | Weak transcription | Breast Myoepithelial Primary Cells | Breast |
45 | chr9:21501400-21504600 | Weak transcription | A549 | lung |
46 | chr9:21502200-21502400 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
47 | chr9:21502200-21502400 | Enhancers | Placenta | Placenta |
48 | chr9:21502200-21502600 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
49 | chr9:21502200-21502800 | Enhancers | HSMM | muscle |
50 | chr9:21502200-21503000 | Enhancers | Breast Myoepithelial Primary Cells | Breast |